Literature DB >> 984801

Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.

L Verbist.   

Abstract

The in vitro antibacterial activity of nine cephalosporins (cephalothin, cephaloridine, cephalexin, cefazolin, cefamandole, cefuroxime, cefatrizine, cefoxitin, and cefazaflur) was determined against 344 strains of Enterobacteriaceae and 99 nonfermentative gram-negative bacilli. Cefamandole, cefazaflur, and cefuroxime were the most active cephalosporins against the Enterobacteriaceae (with the exception of Serratia marcescens). However, cefoxitin was the only cephalosporin that inhibited all 30 S. marcescens strains in a concentration of 16 mug/ml and was by far the most active compound against selected cephalothin-resistant strains of Escherichia coli, Klebsiella, and Proteus mirabilis. Acinetobacter spp. were inhibited best by cefuroxime, but none of the cephalosporins had appreciable activity against the Pseudomonas spp.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984801      PMCID: PMC429810          DOI: 10.1128/AAC.10.4.657

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic.

Authors:  G D Overturf; R L Ressler; P B Marengo; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals.

Authors:  P Actor; J V Uri; J R Guarini; I Zajac; L Phillips; C S Sachs; R M DeMarinis; J R Hoover; J A Weisbach
Journal:  J Antibiot (Tokyo)       Date:  1975-06       Impact factor: 2.649

3.  Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.

Authors:  R P Lewis; R D Meyer; L L Kraus
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

4.  Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin.

Authors:  R C Moellering; M Dray; L J Kunz
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

5.  Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

6.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

7.  Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

8.  In vitro studies of cefamandole.

Authors:  G P Bodey; S Weaver
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

9.  Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.

Authors:  H Wallick; D Hendlin
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

10.  Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

View more
  12 in total

1.  Cefuroxime in the treatment of bacterial infections in seriously ill patients admitted to an intensive care unit.

Authors:  M Gobernado; J Gudin; M Santos; J Gregori; E Canton; C Ferrando
Journal:  Proc R Soc Med       Date:  1977

2.  Cefuroxime: a clinical evaluation.

Authors:  P M Shah; E B Helm; W Stille
Journal:  Proc R Soc Med       Date:  1977

3.  Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.

Authors:  J L Ott; J R Turner; D F Mahoney
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

4.  Pharmacokinetics of cefamandole using a HPLC assay.

Authors:  N S Aziz; J G Gambertoglio; E T Lin; H Grausz; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Chemoprophylaxis with cefoxitin and cephalothin in orthopedic surgery: a comparison.

Authors:  M B Rosenfeld; J Campos; K R Ratzan; I Uredo
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

Review 6.  Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

7.  Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria.

Authors:  M Gurwith; W Albritton; B Lank; G Harding; A Ronald
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

Review 8.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

9.  [In vitro testing of newer cephalosporins (author's transl)].

Authors:  G Linzenmeier; E Rosenthal
Journal:  Infection       Date:  1979       Impact factor: 3.553

10.  The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides.

Authors:  M Stephens; M Potten; A J Bint
Journal:  Infection       Date:  1979       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.